Literature DB >> 2066857

Cerebral edema causing death in children with maple syrup urine disease.

J J Riviello1, I Rezvani, A M DiGeorge, C M Foley.   

Abstract

Four children with the classic form of maple syrup urine disease (MSUD) died of cerebral edema during an intercurrent infection that caused severe dehydration and acidosis. The diagnosis of MSUD had been established during the neonatal period in all four patients, on day 1 of life in three of them. All were in satisfactory control before the intercurrent illness. Two patients underwent peritoneal dialysis. Signs of brain-stem compression occurred after treatment, when biochemical abnormalities were improving. Computed tomography of the head, which was done in two patients, revealed cerebral edema; one of these patients also had subarachnoid hemorrhage. Autopsy in one case revealed cerebral edema with herniation. Our experience documents that cerebral edema may occur in the older child with MSUD as well as in the neonate. The pathogenesis of cerebral edema in MSUD remains unclear. Early treatment of dehydration and acidosis may prevent the catastrophic consequences that we have observed.

Entities:  

Mesh:

Year:  1991        PMID: 2066857     DOI: 10.1016/s0022-3476(05)81036-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience.

Authors:  George V Mazariegos; D Holmes Morton; Rakesh Sindhi; Kyle Soltys; Navdeep Nayyar; Geoffrey Bond; Diana Shellmer; Benjamin Shneider; Jerry Vockley; Kevin A Strauss
Journal:  J Pediatr       Date:  2011-08-11       Impact factor: 4.406

2.  Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.

Authors:  Rukiye Kilicarslan; Alpay Alkan; Demet Demirkol; Huseyin Toprak; Rasul Sharifov
Journal:  Jpn J Radiol       Date:  2012-04-03       Impact factor: 2.374

3.  Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease.

Authors:  P Jouvet; P Rustin; D L Taylor; J M Pocock; U Felderhoff-Mueser; N D Mazarakis; C Sarraf; U Joashi; M Kozma; K Greenwood; A D Edwards; H Mehmet
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

4.  Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population.

Authors:  L Edelmann; M P Wasserstein; R Kornreich; C Sansaricq; S E Snyderman; G A Diaz
Journal:  Am J Hum Genet       Date:  2001-08-16       Impact factor: 11.025

Review 5.  Interrupting the mechanisms of brain injury in a model of maple syrup urine disease encephalopathy.

Authors:  William J Zinnanti; Jelena Lazovic
Journal:  J Inherit Metab Dis       Date:  2011-05-04       Impact factor: 4.982

Review 6.  Diffusion-weighted MR imaging in leukodystrophies.

Authors:  Zoltan Patay
Journal:  Eur Radiol       Date:  2005-07-15       Impact factor: 5.315

Review 7.  Interactions in the Metabolism of Glutamate and the Branched-Chain Amino Acids and Ketoacids in the CNS.

Authors:  Marc Yudkoff
Journal:  Neurochem Res       Date:  2016-10-01       Impact factor: 3.996

Review 8.  Patterns of brain injury in inborn errors of metabolism.

Authors:  Andrea L Gropman
Journal:  Semin Pediatr Neurol       Date:  2012-12       Impact factor: 1.636

9.  The Anaesthetic Management of a Patient with Maple Syrup Urine Disease.

Authors:  Mahmut Alp Karahan; Hüseyin Sert; İnanç Havlioğlu; Hasan Hüsnü Yüce
Journal:  Turk J Anaesthesiol Reanim       Date:  2014-07-11

10.  Classical maple syrup urine disease and brain development: principles of management and formula design.

Authors:  Kevin A Strauss; Bridget Wardley; Donna Robinson; Christine Hendrickson; Nicholas L Rider; Erik G Puffenberger; Diana Shellmer; Diana Shelmer; Ann B Moser; D Holmes Morton
Journal:  Mol Genet Metab       Date:  2010-01-12       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.